Amorphous and crystalline forms of mcl-1 antagonists
US-2024140966-A1 · May 2, 2024 · US
This page is not indexed by search engines while we improve data quality.
Rew Yosup patents
Rew Yosup is listed as an inventor on 16 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Rew Yosup |
| Total patents | 16 |
| First publication | Feb 10, 2015 |
| Latest publication | May 2, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Compounds that inhibit mcl-1 protein
US-2023052348-A1 · Feb 16, 2023 · US
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
US-11407721-B2 · Aug 9, 2022 · US
Compounds that inhibit MCL-1 protein
US-11306107-B2 · Apr 19, 2022 · US
Alpha-hydroxy phenylacetic acid pharmacophore or bioisostere Mcl-1 protein antagonists
US-11274105-B2 · Mar 15, 2022 · US
Compounds that inhibit mcl-1 protein
US-2021230189-A1 · Jul 29, 2021 · US
Alpha-hydroxy phenylacetic acid pharmacophore or bioisostere mcl-1 protein antagonists
US-2021047344-A1 · Feb 18, 2021 · US
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
US-2019062276-A1 · Feb 28, 2019 · US
Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancer
US-2018354918-A1 · Dec 13, 2018 · US
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
US-2017144971-A1 · May 25, 2017 · US
Recent patents
Latest publications not already listed above.
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
US-9593129-B2 · Mar 14, 2017 · US
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
US-9376425-B2 · Jun 28, 2016 · US
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
US-2016137667-A1 · May 19, 2016 · US
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
US-9296736-B2 · Mar 29, 2016 · US
Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancer
US-2016002185-A1 · Jan 7, 2016 · US
Benzoic acid derivative MDM2 inhibitor for the treatment of cancer
US-8952036-B2 · Feb 10, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Amgen Inc | 18 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 14 |
| A61P35/02 | 8 |
| C07D413/06 | 8 |
| C07D498/08 | 8 |
| C07D498/20 | 7 |